Mögliche Prävention der Adriamycin-induzierten Kardiomyopathie durch Verapamil
- 1 November 1984
- journal article
- clinical trial
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 62 (21) , 1032-1037
- https://doi.org/10.1007/bf01711726
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Verapamil, propranolol, and hydralazine protect against the acute cardiac depression induced by adriamycinCardiovascular Research, 1983
- Anthracycline cardiotoxicity: Clinical and pathologic outcomes assessed by radionuclide ejection fractionCancer, 1980
- Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathyThe American Journal of Cardiology, 1980
- Adriamycin cardiotoxicityAmerican Heart Journal, 1980
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyNew England Journal of Medicine, 1979
- Adriamycin and the HeartNew England Journal of Medicine, 1979
- Abnormes Kontraktions- und Füllverhalten des linken Ventrikels bei Tumorpatienten unter Adriamycin-TherapieDeutsche Medizinische Wochenschrift (1946), 1978
- Inhibition of the cardiac mitochondrial calcium pump by adriamycin in vitroBiochemical Medicine, 1977
- MITOCHONDRIAL CALCIUM OVERLOAD: A GENERAL MECHANISM FOR CELL-NECROSIS IN MUSCLE DISEASESThe Lancet, 1976
- Echocardiographic Assessment of Left Ventricular FunctionCirculation, 1974